Peter G. Traber, President & CEO at GALECTIN THERAPEUTICS INC (GALT), sold 70,000 shares at $5.86 ($410K) on 2018-06-08, disclosed to the SEC on 2018-06-12.
Open-market sale of $410k GALT by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SELB | SELL | 2022-01-07 | $10K | — | Filing → |
| SELB | SELL | 2021-12-14 | $12K | — | Filing → |
| SELB | SELL | 2021-10-15 | $16K | — | Filing → |